| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |